瑞普生物
(300119)
| 流通市值：57.29亿 | | | 总市值：79.80亿 |
| 流通股本：3.34亿 | | | 总股本：4.65亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 568,317,746.66 | 651,187,038.58 | 486,904,900.47 | 532,964,024.05 |
| 交易性金融资产 | 1,113,158,780.07 | 1,042,700,118.27 | 1,306,801,332.2 | 1,326,172,881.78 |
| 应收票据及应收账款 | 1,120,721,218.55 | 1,009,525,204.1 | 1,063,343,120.7 | 1,100,972,432.97 |
| 其中：应收票据 | 20,014,438.29 | 25,925,814.21 | 27,517,345.75 | 23,624,351.08 |
| 应收账款 | 1,100,706,780.26 | 983,599,389.89 | 1,035,825,774.95 | 1,077,348,081.89 |
| 应收款项融资 | 9,446,693.07 | 8,322,771.9 | 17,901,174.42 | 14,935,076.44 |
| 预付款项 | 84,837,689.73 | 71,341,123.25 | 114,400,386.91 | 108,822,448.55 |
| 其他应收款合计 | 92,907,989.98 | 72,556,976.85 | 102,581,705.32 | 72,919,033.23 |
| 存货 | 521,705,345.38 | 502,117,273.6 | 505,796,956.07 | 532,354,914.76 |
| 其他流动资产 | 24,129,465.45 | 16,852,862.54 | 14,373,740.68 | 11,961,526.04 |
| 流动资产合计 | 3,535,224,928.89 | 3,374,603,369.09 | 3,612,103,316.77 | 3,701,102,337.82 |
| 非流动资产: | | | | |
| 长期应收款 | 1,344,884.46 | 1,491,357.8 | 1,621,766.37 | 1,955,408.77 |
| 长期股权投资 | 1,349,526,868.06 | 1,347,828,101.32 | 1,148,889,057.32 | 1,098,769,083.34 |
| 其他非流动金融资产 | 49,066,551.63 | 53,349,733.37 | 53,494,000.85 | 66,263,636.26 |
| 投资性房地产 | 32,471,985.01 | 33,470,212.09 | 34,468,439.14 | 35,466,666.22 |
| 固定资产 | 1,585,599,739.53 | 1,619,177,205.22 | 1,561,341,603.22 | 1,783,072,833.15 |
| 在建工程 | 62,250,720.36 | 31,889,731.39 | 99,571,615.44 | 64,431,375.74 |
| 使用权资产 | 5,936,585.28 | 8,356,783.66 | 11,355,878.23 | 13,227,765.18 |
| 无形资产 | 470,874,505.29 | 484,053,690.53 | 447,174,489.78 | 474,453,435.94 |
| 开发支出 | 203,577,248.22 | 197,044,437.22 | 199,407,334.35 | 201,691,230.81 |
| 商誉 | 442,989,818.37 | 442,989,818.37 | 442,473,678.38 | 443,364,365.47 |
| 长期待摊费用 | 1,417,614.1 | 1,397,684.25 | 1,460,809.8 | 1,188,024.25 |
| 递延所得税资产 | 37,070,738.55 | 36,947,810.04 | 29,873,629.73 | 29,923,471.62 |
| 其他非流动资产 | 24,972,829.76 | 23,309,774.27 | 47,652,629.57 | 40,071,235.44 |
| 非流动资产合计 | 4,267,100,088.62 | 4,281,306,339.53 | 4,078,784,932.18 | 4,253,878,532.19 |
| 资产总计 | 7,802,325,017.51 | 7,655,909,708.62 | 7,690,888,248.95 | 7,954,980,870.01 |
| 流动负债: | | | | |
| 短期借款 | 860,927,049.84 | 785,593,744.31 | 736,812,759.18 | 883,745,457.48 |
| 应付票据及应付账款 | 480,319,251.05 | 436,830,223.47 | 488,861,492.51 | 514,862,401.23 |
| 其中：应付票据 | 149,875,869.86 | 100,810,918.14 | 168,182,006.68 | 197,445,747.08 |
| 应付账款 | 330,443,381.19 | 336,019,305.33 | 320,679,485.83 | 317,416,654.15 |
| 预收款项 | 129,358.23 | 101,592.77 | 5,589,870.4 | 8,099,700.6 |
| 合同负债 | 59,675,653.75 | 72,656,719.45 | 50,846,163.99 | 42,368,244.15 |
| 应付职工薪酬 | 34,607,839.93 | 52,322,917.68 | 36,353,709.82 | 37,523,741.09 |
| 应交税费 | 45,148,764.29 | 30,046,426.58 | 43,550,835.73 | 35,976,619.7 |
| 其他应付款合计 | 146,354,125.18 | 180,531,315.13 | 272,684,825.22 | 393,285,010.4 |
| 应付股利 | 29,750,000 | - | - | 23,303,105.81 |
| 一年内到期的非流动负债 | 302,232,241.31 | 303,719,284.91 | 71,107,589.81 | 64,855,107.03 |
| 其他流动负债 | 28,986,108.01 | 27,804,836.6 | 27,022,134.56 | 18,422,113.39 |
| 流动负债合计 | 1,958,380,391.59 | 1,889,607,060.9 | 1,732,829,381.22 | 1,999,138,395.07 |
| 非流动负债: | | | | |
| 长期借款 | 360,355,900 | 368,423,036.2 | 624,876,252.89 | 667,125,639.36 |
| 租赁负债 | 3,875,078.04 | 2,584,702.58 | 4,494,564.44 | 6,303,813.31 |
| 递延收益 | 91,015,597.45 | 92,655,861.28 | 58,456,955.93 | 59,793,790.39 |
| 递延所得税负债 | 117,048,747.15 | 118,015,598.77 | 120,188,332.82 | 131,744,993.92 |
| 非流动负债合计 | 572,295,322.64 | 581,679,198.83 | 808,016,106.08 | 864,968,236.98 |
| 负债合计 | 2,530,675,714.23 | 2,471,286,259.73 | 2,540,845,487.3 | 2,864,106,632.05 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 464,754,706 | 464,754,706 | 464,754,706 | 464,754,706 |
| 资本公积 | 2,144,673,763.43 | 2,144,673,763.43 | 2,153,002,323.2 | 2,147,521,313.52 |
| 减:库存股 | 191,211,941.65 | 191,211,941.65 | 191,211,941.65 | 191,211,941.65 |
| 其他综合收益 | 45,528.73 | 45,528.73 | - | - |
| 盈余公积 | 232,923,953 | 232,923,953 | 233,576,150.02 | 232,923,953 |
| 未分配利润 | 2,159,675,210.16 | 2,051,896,990.9 | 2,013,038,363.14 | 1,907,905,976.14 |
| 归属于母公司股东权益合计 | 4,810,861,219.67 | 4,703,083,000.41 | 4,673,159,600.71 | 4,561,894,007.01 |
| 少数股东权益 | 460,788,083.61 | 481,540,448.48 | 476,883,160.94 | 528,980,230.95 |
| 股东权益合计 | 5,271,649,303.28 | 5,184,623,448.89 | 5,150,042,761.65 | 5,090,874,237.96 |
| 负债和股东权益合计 | 7,802,325,017.51 | 7,655,909,708.62 | 7,690,888,248.95 | 7,954,980,870.01 |
| 公告日期 | 2026-04-28 | 2026-03-31 | 2025-10-25 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |